RECCE PHARMACEUTICALS LTD

ASX: RCE

Sector: Sector:Health Care
Industry group: Industry:Pharmaceuticals, Biotechnology & Life Sciences

RCE News & Analysis

RCEHealth CareCompany Update19 August 2026· 2 min read

Recce Pharmaceuticals (ASX: RCE) Wins Approval for Phase 3 Comparator Study

Recce Pharmaceuticals will add a 208-patient, active-controlled study to its Australian Phase 3 R327G program. An interim analysis is planned after 104 participants.

Latest RCE ASX Announcements

19 Aug 2026 · 9:02 pmCompany Update
HREC Approves Comparator Study for Pivotal Phase 3 DFI
19 Aug 20269:02 pmHREC Approves Comparator Study for Pivotal Phase 3 DFICompany Update
7 Aug 2026 · 2:55 amDirector Interests
Change of Director's Interest Notices (x4)
7 Aug 20262:55 amChange of Director's Interest Notices (x4)Director Interests
5 Aug 2026 · 2:12 amSecurities Administration
Cleansing Notice
5 Aug 20262:12 amCleansing NoticeSecurities Administration
3 Aug 2026 · 6:23 pmOther
Application for quotation of securities - RCE
3 Aug 20266:23 pmApplication for quotation of securities - RCEOther
31 July 2026 · 9:32 pmCapital Raising
Completion of Share Purchase Plan and Shortfall Notice
31 July 20269:32 pmCompletion of Share Purchase Plan and Shortfall NoticeCapital Raising
31 July 2026 · 9:30 pmOther
Application for quotation of securities - RCE
31 July 20269:30 pmApplication for quotation of securities - RCEOther
31 July 2026 · 7:04 pmMeetings & Governance
Notice of General Meeting/Proxy Form
31 July 20267:04 pmNotice of General Meeting/Proxy FormMeetings & Governance
30 July 2026 · 8:38 pmCompany Update
U.S. Government Releases US$66.9B AMR Biodefense Strategy
30 July 20268:38 pmU.S. Government Releases US$66.9B AMR Biodefense StrategyCompany Update
21 July 2026 · 10:50 pmPresentations
Investor Webinar - Q4 FY26 Investor Presentation Deck
21 July 202610:50 pmInvestor Webinar - Q4 FY26 Investor Presentation DeckPresentations
21 July 2026 · 10:27 pmPresentations
Investor Webinar - 2.30PM (AEST) 21 July 2026
21 July 202610:27 pmInvestor Webinar - 2.30PM (AEST) 21 July 2026Presentations
21 July 2026 · 10:20 pmQuarterly Reports
Quarterly Activities/Appendix 4C Cash Flow Report
21 July 202610:20 pmQuarterly Activities/Appendix 4C Cash Flow ReportQuarterly Reports
20 July 2026 · 7:33 pmSecurities Administration
Update - Proposed issue of securities - RCE
20 July 20267:33 pmUpdate - Proposed issue of securities - RCESecurities Administration
20 July 2026 · 7:29 pmCapital Raising
Extension to Share Purchase Plan Closing Date
20 July 20267:29 pmExtension to Share Purchase Plan Closing DateCapital Raising
14 July 2026 · 6:56 pmCompany Update
Vietnamese Patent Granted for RECCE Anti-Infectives
14 July 20266:56 pmVietnamese Patent Granted for RECCE Anti-InfectivesCompany Update
6 July 2026 · 7:06 pmCapital Raising
Share Purchase Plan - Letter and Offer Booklet
6 July 20267:06 pmShare Purchase Plan - Letter and Offer BookletCapital Raising

View complete RCE announcement history →

RECCE PHARMACEUTICALS LTD

RCE Share Price

RCE News & Analysis

Recce Pharmaceuticals (ASX: RCE) Wins Approval for Phase 3 Comparator Study

Latest RCE ASX Announcements